Results 21 to 30 of about 20,363 (253)
THE ROLE OF ANTICOAGULATION THERAPY IN PATIENTS WITH PROSTHETIC HEART VALVES
Cardiac surgery is the only radical method of treatment of valvular defects (congenital or acquired): valve preservation procedures or prosthetics operations.
N. A. Shostak +4 more
doaj +1 more source
Mid-term results of open transaortic implantation of the «MedLab-CT» prosthesis: prospective clinical study [PDF]
Aim. To evaluate the mid-term clinical and hemodynamic results of open transaortic implantation of the balloon-expandable prosthesis MedLab-CT in patients with high surgical risk. Material and methods. The study included 41 patients (mean age 65.711.7
Vladlen V. Bazylev +4 more
doaj +1 more source
Background Glutaraldehyde fixed xenogeneic heart valve prosthesis are hindered by calcification and lack of growth potential. The aim of tissue decellularization is to remove tissue antigenicity, avoiding the use of glutaraldehyde and improve valve ...
Mathieu van Steenberghe +8 more
doaj +1 more source
Bioprosthetic Aortic Valve Degeneration: a Review from a Basic Science Perspective
Introduction: The increase in the prevalence of aortic stenosis due to an aging population has led to an increasing number of surgical aortic valve replacements.
Tiago R Velho +5 more
doaj +1 more source
Bridging aortic valve surgery to 21st century. what can a surgeon do [PDF]
Aortic valve stenosis is the most clinically relevant valvular heart disease in the elderlies. Surgical aortic valve replacement (SAVR) represented, for decades, the standard of care for the treatment of severe aortic stenosis.
Barretta, Antonio +13 more
core +1 more source
Detecting Aortic Valve Anomaly From Induced Murmurs: Insights From Computational Hemodynamic Models
Patients who receive transcatheter aortic valve replacement are at risk for leaflet thrombosis-related complications, and can benefit from continuous, longitudinal monitoring of the prosthesis.
Shantanu Bailoor +3 more
doaj +1 more source
Background CORKNOT® facilitates a reduction in cardiopulmonary bypass (CPB) time, aortic cross clamp (ACC) time and operative time, but reported to be associated with other complications. We aim to quantify the incidence of valvular complications related
Faizus Sazzad +5 more
doaj +1 more source
Long-term survival following aortic valve replacement : the influence of age, prosthesis-patient mismatch and indexed effective orifice area [PDF]
Background: Prosthesis-patient mismatch (PPM) has been linked to reduced long-term survival after aortic valve replacement. We studied the influence of age, PPM and indexed effective orifice area (iEOA) in this setting. Methods Patients (n=586) subjected
Camilleri, Liberato +2 more
core +3 more sources
Objective: Bioprosthetic heart valves (BHVs) are commonly used in surgical and percutaneous valve replacement. The durability of percutaneous valve replacement is unknown, but surgical valves have been shown to require reintervention after 10 to 15 years.
Jae H. Lee, PhD +5 more
doaj +1 more source
There are more than 300,000 heart valves implanted annually worldwide with about 50% of them being mechanical valves. The heart valve replacement is often a common treatment for severe valvular disease.
Gamage, Peshala T. +2 more
core +1 more source

